O-RAN-ALLIANCE-E.V.
As of January 2021, the O-RAN ALLIANCE welcomes LG U+ as its 28th operator member. With strong support by its expanding number of contributors, the alliance now counts more than 260 companies from around the globe, building a foundation and unifying the Radio Access Networks (RAN) industry towards open, intelligent, virtualized and fully interoperable RAN solutions.
O-RAN Open Summit (Virtual) Complements the O-RAN Demos at MWC Shanghai 2021
For latest updates on the evolution of open RAN, the O-RAN ALLIANCE invites interested industry participants to the O-RAN Open Summit . This compact virtual event will open with operator executives delivering a summary of O-RAN’s progress and developments. Subsequent keynotes and panel discussions with major O-RAN players will summarize the achievements and next steps in the O-RAN specification effort, testing and integration, and delivery of open software for the RAN.
The O-RAN Open Summit virtual event is scheduled for February 25, 2021 from 9:00-11:00pm China Standard Time (8:00-10:00am EST, 14:00-16:00 CET). For more information and to join the summit free of charge, please visit our website .
O-RAN Demonstrations at MWC Shanghai 2021 and at the O-RAN Virtual Showcase
Two O-RAN demonstrations are planned to be presented at the MWC Shanghai 2021:
- Sageran is demonstrating a complete O-RAN white-box small cell solution based on an x86 platform with an FPGA Accelerator card that showcases a stand-alone end-to-end use case using white box hardware for an indoor cell which supports MIMO with 4T4R. The demo is hosted at MWC Shanghai 2021 by Sageran, booth N2.C114 , as well as at the O-RAN Virtual Exhibition .
- VIAVI and Rohde & Schwarz are jointly demonstrating validation of open fronthaul performance. As network operators adopt disaggregated, multi-vendor networks, rigorous testing of performance and interoperability must accompany conformance testing. This demo showcases generation and delivery of typical standards based testcase IQ data to the O-RU utilizing the Lower Layer Split Option 7.2x fronthaul interface with the VIAVI TM500 O-RU Tester. Moreover, uplink and downlink fronthaul logs are captured, and RF signal generation and capture are performed using the Rohde & Schwarz VSG and VSA hardware with VSE Software for RF and IQ signal analysis. Testcase workflow is simplified for the end user utilizing the VIAVI O-RU Test Manager, providing a single point of test control. The demo is hosted at MWC Shanghai 2021 by VIAVI Solutions, booth N1.B137 , as well as at the O-RAN Virtual Exhibition .
5 more virtual demos for MWC Shanghai 2021 have enriched the O-RAN Virtual Exhibition :
- ITRI is demonstrating traffic steering xApps and Near-Real-Time Radio Intelligent Controller platform utilizing E2 procedures to monitor cell and UE metrics generated by RAN simulator and to offload some UE to neighbor cells such that the A1 policy is guaranteed.
- NVIDIA and VMWare are jointly demonstrating PoC of Aerial 5G gNB Layer-1 orchestration on VMWare telco cloud platform. This demo showcases NVIDIA Aerial SDK as cloud native function, with docker containers and Kubernetes manifests. Aerial cuBB onboarded to VMWare telco cloud platform offers service agility, operational efficiency and reduced CAPEX/OPEX through MANO.
- Viettel is demonstrating an end-to-end-solution based on Intel server (Xeon-D) with NIC (XXV710-DA2T) that is integrated with an outdoor micro O-RU via an Open Fronthaul Interface. The base station connects with EPC and Viettel’s eNB perform a complete NSA (Option 3X) white-box base station solution and ready for Commercial Deployment. The integrated system is verified using a commercial UE through the attach and speed test.
- Altiostar has teamed up with Airtel and NEC to demonstrate interoperability testing and integration of massive MIMO radio units (O-RU) and virtualized distributed units (O-DU) running on commercial-off-the-shelf (COTS) servers. The demonstration features a commercial end-to-end Open Fronthaul interface based on O-RAN specifications.
- Parallel Wireless is demonstrating 2G, 3G, 4G and 5G O-RAN based macro Open RAN to expand and modernize cellular networks with reduced TCO & simplified maintenance. It’s been proven in rural in 50+ networks globally and is now scalable for urban 2G 3G 4G while unleashing the full 5G potential.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 260 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations. For more information please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218006088/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom